Xvivo Perfusion AB(DE:3XV)
€18.10+0.36 (+1.29%)
DE:3XV
Xvivo Perfusion AB Revenue
€18.10
At close:+0.36 (+1.29%)
Xvivo Perfusion AB (3XV) Revenue
0 Followers
Xvivo Perfusion AB Revenue
Xvivo Perfusion AB had a revenue of 252.56M in the quarter ending Sep 30, 2026, with 5.68%. This bring the company's revenue in the last twelve months to 958.65M, Increased 7.08%. In the fiscal year ending Dec 31, 2025, Xvivo Perfusion AB had annual revenue of 812.16M with -1.25% growth.
- Revenue (ttm)
- 958.65M
- Revenue Growth
- 21.17%
- P/S Ratio
- 0.72
- Revenue/Employee
- EUR 3,923,502
- Employees
- 207
- Market Cap
- EUR 581.07M
Revenue Chart
Xvivo Perfusion AB Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 812.16M | -10.25M | -1.25% |
| Dec 31, 2024 | 822.41M | 224.87M | 37.63% |
| Dec 31, 2023 | 597.54M | 182.25M | 43.88% |
| Dec 31, 2022 | 415.29M | 156.91M | 60.73% |
| Dec 31, 2021 | 258.39M | 78.53M | 43.66% |
| Dec 31, 2020 | 179.86M | -40.98M | -18.56% |
| Dec 31, 2019 | 220.84M | 32.97M | 17.55% |
| Dec 31, 2018 | 187.87M | 39.53M | 26.65% |
| Dec 31, 2017 | 148.34M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.